- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03969407
Determination of the Best Positive End-expiratory Pressure (PEEP) (DROP)
Determination of the Best Positive End-expiratory Pressure (PEEP) Based on Oxygenation or Driving Pressure in Patients With Acute Respiratory Distress Syndrome After Cardiac Thoracic Surgery
Determination of the best positive end-expiratory pressure (PEEP) based on oxygenation or driving pressure in patients with acute respiratory distress syndrome (ARDS) after cardiothoracic surgery
The use of a positive end-expiratory pressure in acute respiratory distress syndrome is obvious in ARDS management. On the one hand it serves to fight against the reduction of functional residual capacity (FRC) and enable the limitation of hypoxia; and on the other hand it allows the limitation of "opening/closing" lesions in pulmonary alveoli which lead to increase "bio trauma".
However elevated PEEP has harmful effect such as hemodynamic effect on the right ventricle and distension on healthy part of the lung.Other adverse effects are: decreasing cardiac output, increased risk of barotrauma, and the interference with assessment of hemodynamic pressures.
Ideally the adjustment of PEEP level must be done by taking into account each patient characteristic. PEEP titration based on blood gas analysis is one of the most used techniques by physicians.
Current guidelines for lung-protective ventilation in patients with acute respiratory distress syndrome (ARDS) suggest the use of low tidal volumes (Vt), set according to ideal body weight (IBW) of the patient, and higher levels of positive end-expiratory pressure (PEEP) to limit ventilator-induced lung injury (VILI). However, recent studies have shown that ARDS patients who are ventilated according to these guidelines may still be exposed to forces that can induce or aggravate lung injury.
Driving pressure (DP) is the difference between the airway pressure at the end of inspiration (plateau pressure, Ppl) and PEEP.
Driving pressure may be a valuable tool to set PEEP. Independent of the strategy used to titrate PEEP, changes in PEEP levels should consider the impact on driving pressure, besides other variables such as gas exchange and hemodynamics. A decrease in driving pressure after increasing PEEP will necessarily reflect recruitment and a decrease in cyclic strain. On the contrary, an increase in driving pressure will suggest a non-recruitable lung, in which overdistension prevails over recruitment.
The main purposes of this study are to assess the optimal PEEP based on the best driving pressure or the best oxygenation.
Studieoversigt
Status
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Le Plessis-Robinson, Frankrig, 92350
- Centre chirurgical Marie Lannelongue
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- All Patients admitted for intensive care with acute respiratory distress syndrome intubated according to the criteria of the Berlin Consensus
Exclusion Criteria:
- Undrained pneumothoraces
- Hemodynamic instability defined by increased need of vasopressors and / or an systolic arterial pressure below 90 mmHg
- Hypovolemic shock
- Bronchopleural fistula
- High intracranial pressure
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Best PEEP level based on the best driving pressure value
Tidsramme: 1 DAY
|
1 DAY
|
|
Best PEEP level based on the best oxygenation value defined by the PaO2/FiO2 ratio.
Tidsramme: 1 DAY
|
1 DAY
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2018-A01760-55
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Acute respiratory distress syndrom
-
Rise Therapeutics LLCIkke rekrutterer endnuAcute respiratory distress syndrom
-
PT. Prodia Stem Cell IndonesiaRumah Sakit Pusat Angkatan Darat Gatot SoebrotoRekrutteringAcute respiratory distress syndromIndonesien
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Ikke rekrutterer endnu
-
Changchun Tuohua Pharmaceutical Co., Ltd.RekrutteringAcute respiratory distress syndromKina
-
Southeast University, ChinaRekrutteringAcute respiratory distress syndromKina
-
Southeast University, ChinaRekrutteringAcute respiratory distress syndromKina
-
Assiut UniversityIkke rekrutterer endnuAcute respiratory distress syndrom
-
Breathe Biologics, Inc.Ikke rekrutterer endnu
-
Wu RongzhouAfsluttetAcute respiratory distress syndrom | Lungebetændelse hos børn | Åndedrætssvigt (pædiatriske patienter)Kina
-
Centre Hospitalier Universitaire, AmiensIkke rekrutterer endnuAcute respiratory distress syndrom | Ventilator-induceret lungeskade | Højde | Tidevandsvolumen | Forventet kropsvægtFrankrig